- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04589559
The Care After Life-threatening Medical Events Study (CALME)
The Care After Life-threatening Medical Events (CALME) Pilot Study: An Investigation of Heart Rate Variability Biofeedback Training
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
HRV biofeedback is a technique that combines slow paced breathing with the use of accurate, moment-to-moment physiological monitoring. The goal is to make internal cardiac information available to people in order to help them learn how to increase the beat-to-beat variability in their heart's activity and thereby increase parasympathetic activity of the autonomic nervous system. Apart from active interventions such as exercise training that reliably increase HRV but that may be inappropriate for many cardiac patients, HRV biofeedback is an easy-to-implement technique which allows people to monitor and then ultimately alter their parasympathetic activity.
Research is needed to determine whether HRV biofeedback training has beneficial consequences for mental and cardiovascular health in patients who have experienced serious, life-threatening cardiac events. The investigator believes that cardiac arrest survivors, in particular, may stand to benefit from such an intervention because many of them experience clinically significant psychological distress after their medical event.
Distressed cardiac patients may be especially motivated to learn to influence their own heart activity in order to improve their own HRV, reduce their cardiovascular risk, and lessen their symptoms of psychological distress. Therefore, it may be wise to harness this motivation in the service of helping these patients deliberately learn to alter their own autonomic activity rather than simply breathing at a rate that automatically improves HRV without any learning process. By providing patients with an external (e.g., visual) form of feedback about their otherwise largely inaccessible autonomic physiology (i.e., vagus nerve activity), the investigator will conduct a feasibility study of HRV biofeedback training with the goal of increasing HRV and reducing anxiety symptoms.
The purpose of this pilot study is to examine the feasibility of enrolling 10 participants and assessing the feasibility, acceptability, appropriateness, and usability of the at-home, multi-week HRV biofeedback training as well as participants' compliance with the intervention. Additionally, the purpose of the study is to assess whether participants generally show a decrease in cardiac-related interoceptive fear, a decrease in trait anxiety, a decrease in negative affect, and an increase in HRV during the course of the study. The data collected from participants as part of this feasibility pilot will influence the decision to continue with a larger randomized clinical trial using the methods in this pilot together with a control group. Progress will be monitored with Polar H10 heart rate monitor - a supremely precise heart rate sensor that comes with the Polar Pro chest strap. It will be used with a smartphone app Elite HRV - which is non-experimental.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10032
- Columbia University Irving Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 years or older
- Fluent in English
- A diagnosis of cardiac arrest (CA)
- Time elapsed since their CA is less than 72 months
- Elevated post-traumatic stress disorder (PTSD) symptom total scores on the 17-item Post-Traumatic Stress Disorder Checklist (PCL) of 30 or higher (i.e., greater than the median in a prior sample of cardiac arrest survivors) or elevated PCL-5 scores of 30 or higher or Acute Stress Disorder Scale (ASDS) scores of 34 or higher
- Owns either an iPhone or Android smartphone in order to run the app involved in the intervention
Exclusion Criteria:
- Breathing difficulty that does not allow participant to complete the intervention
- Inability to comply with the protocol (either self-selected or indicated during screening that s/he could not complete all requested tasks). This includes, but is not limited to, patients with a level of cognitive impairment indicative of dementia and patients with current alcohol or substance abuse, and patients with severe mental illness (e.g., schizophrenia).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention: Heart Rate Variability Biofeedback
Participants in this intervention group complete at-home heart rate variability biofeedback (HRVB) training using a chest-worn heart rate monitor and a smartphone app.
They complete at least 10 minutes per day of HRVB training on at least 5 days per week for 3 weeks.
|
First, participants are taught how to do relaxed, abdominal breathing.
Second, they are taught how to breathe at a slow rate of 0.1 Hz (i.e., one completed breath cycle every 10 seconds).
Third, they are taught how to monitor their heart rate variability (HRV) in real time using the smartphone app, which receives data wirelessly via Bluetooth from the heart rate monitor.
Participants are instructed that their goal is to increase their HRV during the three weeks of at-home practice.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Eligible Cardiac Arrest (CA) Survivors Whom we Approach Who Ultimately Agree to Participate in the Pilot Study
Time Frame: Baseline/Visit 1
|
This is to assess the feasibility of enrollment in the trial.
The denominator for this metric is the number of potential participants who were approached and contacted by the study team who were determined to be eligible for the study.
The numerator is the number of participants who enrolled in the study (i.e., 10 participants).
|
Baseline/Visit 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Enrolled Participants Who Complete the Pilot Study
Time Frame: Pre-training/Visit 2, Post-training/Visit 3 (approximately 3 weeks apart)
|
This is to assess successful program adherence.
|
Pre-training/Visit 2, Post-training/Visit 3 (approximately 3 weeks apart)
|
Percentage of Participants Who Complete a Majority of the At-home HRVB Sessions for the Pilot Study
Time Frame: Pre-training/Visit 2, Post-training/Visit 3 (approximately 3 weeks apart)
|
As a measure of intervention compliance, this is to assess the percentage of participants who complete a majority (>= 8 of 15) of the at-home HRVB sessions.
|
Pre-training/Visit 2, Post-training/Visit 3 (approximately 3 weeks apart)
|
Percentage of Participants Who Report Adequate Feasibility
Time Frame: Post-training/Visit 3 (approximately 3 weeks)
|
This is to assess the intervention's feasibility.
The percentage of participants who report scores >= 4 for the feasibility total score reflects the percentage of participants who indicated that the intervention is adequately feasible.
|
Post-training/Visit 3 (approximately 3 weeks)
|
Percentage of Participants Who Report Adequate Acceptability
Time Frame: Post-training/Visit 3 (approximately 3 weeks)
|
This is to assess the intervention's acceptability.
The percentage of participants who report scores >= 4 for the acceptability total score reflects the percentage of participants who indicated that the intervention is adequately acceptable.
|
Post-training/Visit 3 (approximately 3 weeks)
|
Percentage of Participants Who Report Adequate Appropriateness
Time Frame: Post-training/Visit 3 (approximately 3 weeks)
|
This is to assess the intervention's appropriateness for reducing anxiety, the proportion of participants who report scores >= 4 would be adequate. This is to assess the intervention's appropriateness for reducing anxiety. The percentage of participants who report scores >= 4 for the appropriateness-for-reducing-anxiety total score reflects the percentage of participants who indicated that the intervention is adequately appropriate for reducing anxiety. |
Post-training/Visit 3 (approximately 3 weeks)
|
Percentage of Participants Who Report Adequate Usability
Time Frame: Post-training/Visit 3 (approximately 3 weeks)
|
We will assess the percentage of participants who report total scores >= 68 for their rating of the intervention's usability using the System Usability Scale.
|
Post-training/Visit 3 (approximately 3 weeks)
|
Visit-2-to-3 Change in Cardiac-related Interoceptive Fear
Time Frame: Pre-training/Visit 2, Post-training/Visit 3 (approximately 3 weeks apart)
|
This is to assess the Visit-2-to-3 change in cardiac-related interoceptive fear measured as the within-person difference in the sum of the four cardiac-related items from the physical subscale of the Anxiety Sensitivity Index.
The total score ranges from a minimum of 0 units on a scale to a maximum of 16 units on a scale.
Lower scores indicate lower anxiety.
|
Pre-training/Visit 2, Post-training/Visit 3 (approximately 3 weeks apart)
|
Visit-2-to-3 Change in Trait Anxiety
Time Frame: Pre-training/Visit 2, Post-training/Visit 3 (approximately 3 weeks apart)
|
This is to assess the Visit-2-to-3 change in trait anxiety measured as the within-person difference in the total score of the trait version of the State-Trait Anxiety Inventory.
The total score ranges from a minimum of 20 units on a scale to a maximum of 80 units on a scale.
Higher scores indicate higher anxiety.
|
Pre-training/Visit 2, Post-training/Visit 3 (approximately 3 weeks apart)
|
Visit-2-to-3 Change in Trait Negative Affect
Time Frame: Pre-training/Visit 2, Post-training/Visit 3 (approximately 3 weeks apart)
|
This is to assess the Visit-2-to-3 change in trait negative affect measured as the within-person difference in the total score of the negative subscale of the Positive and Negative Affect Schedule.
The total score ranges from a minimum of 10 units on a scale to a maximum of 50 units on a scale.
Lower scores represent lower levels of Negative Affect.
|
Pre-training/Visit 2, Post-training/Visit 3 (approximately 3 weeks apart)
|
Heart Rate Variability (HRV)
Time Frame: Up to 3 weeks (starting after Visit 2 and extending until Visit 3)
|
This is to assess HRV using participants' exported and deidentified data from the Elite HRV smartphone app.
Specifically, HRV is operationalized as the natural log of the root mean square of the successive difference (lnRMSSD), a standard measure of beat-to-beat HRV.
This HRV measure is recorded for each at-home training session completed by participants using the app and the heart rate monitor.
|
Up to 3 weeks (starting after Visit 2 and extending until Visit 3)
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAAS9001
- P30AG064198 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Arrest
-
Italian Resuscitation CouncilUnknownOut-Of-Hospital Cardiac Arrest | In-hospital Cardiac ArrestItaly
-
Emergency Medical Services, Capital Region, DenmarkOdense University Hospital; TrygFonden, Denmark; Aalborg University HospitalUnknownOut-Of-Hospital Cardiac Arrest | Pediatric Disorder | Cardiopulmonary ArrestDenmark
-
Medical University of ViennaLudwig Boltzmann Institute Digital Health and Patient Safety; Emergency Medical...RecruitingCardiac Arrest, Out-Of-HospitalAustria
-
University Medical Centre MariborOHK Medical DevicesRecruiting"The Effect of the Use of an Autotransfusion Device on Hemodynamic Parameters During Resuscitation".Cardiac Arrest | Out of Hospital Cardiac ArrestSlovenia
-
National Taiwan University HospitalRecruitingOut-Of-Hospital Cardiac ArrestTaiwan
-
Far Eastern Memorial HospitalRecruitingOut-Of-Hospital Cardiac ArrestTaiwan
-
King's College LondonKing's College Hospital NHS Trust; London Ambulance Service NHS TrustNot yet recruiting
-
Wroclaw Medical UniversityWroclaw Emergency Medical ServicesRecruiting
-
Sunnybrook Health Sciences CentrePrescott-Russell Paramedic Service; Peterborough Paramedic Service; Bruce County... and other collaboratorsRecruiting
-
Emergency Medical Services, Capital Region, DenmarkTrygFonden, Denmark; Danish Heart Foundation; Zoll Medical CorporationRecruitingOut-Of-Hospital Cardiac ArrestDenmark
Clinical Trials on Heart Rate Variability Biofeedback Training
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawn
-
University of California, San DiegoUnknown
-
University Hospital, MontpellierRecruitingPsychogenic DystoniaFrance
-
University of Southern CaliforniaNational Institute of Mental Health (NIMH)Recruiting
-
University of Lausanne HospitalsCompletedStress | Premature Birth | Anxiety | Maternal Distress - DeliveredSwitzerland
-
National Defense Medical Center, TaiwanCompletedPsychological Distress | Acute Ischemic Stroke | Biofeedback | Autonomic Dysfunction, Cognitive Function
-
National Defense Medical Center, TaiwanRecruitingChronic Kidney Diseases | Inflammatory Response | Autonomic DysfunctionTaiwan
-
Prisma Health-UpstateUniversity of South CarolinaCompleted
-
Rutgers, The State University of New JerseyWithdrawnASTHMA | ANXIETY